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The inhibition of the enzymes trypsin, plasmin, and thrombin by benzyl 4-guanidinobenzoate and 4P-nitrobenzyl 
4-guanidinobenzoate is caused by acylation of the active site. Second order ate constants were determined. 
1. Introduction 
Recently benzyl 4-guanidinobenzoate (BGB) and 
4'-nitrobenzyl 4-guanidinobenzoate (NBGB) were 
described as very potent competitive inhibitors of 
trypsin [ 1 ]. Since other esters of 4-guanidinobenzoic 
acid are known to inhibit the enzyme by forming 
covalent bonds [2-4] ,  the mode of action of BGB 
and NBGB was reinvestigated. Furthermore, the ac- 
tion of these compounds against plasmin and thrombin 
was studied. 
2. Materials and methods 
2.1. lnhibitors, enzymes, and substrates 
Benzyl 4-guanidinobenzoate (BGB). HNO 3 , 
4'-nitrobenzyl 4-guanidinobenzoate (NBGB). HNO3, 
and 4-nitrobenzyl a cohol were kindly supplied by 
Prof. Dr. G.Wagner, Sektion Biowissenschaften, Karl- 
Marx-Universit~it Leipzig. Trypsin (E.C. 3.4.4.4), a
crystallized preparation from bovine pancreas (Spofa, 
Prague) containing approximately 50 percent mag- 
nesium sulphate, plasmin (E.C. 3.4.4.14) was obtained 
from human plasminogen prepared according to Wal- 
i6n [5], specific activity: 40 caseinolytic units per mg 
nitrogen by activation with streptokinase atpH 7.2 
(0.35 units of streptokinase p r caseinolytic unit of 
plasminogen). Thrombin (E.C. 3.4.4.13) prepared from 
bovine blood according to Walsmann [6], specific 
activity 1300 NIH-units per mg. Streptokinase, Strep- 
tase® from Behring Werke AG, Marburg/Lahn. 
Fibrinogen, abovine preparation from Behring Werke 
AG, Marburg/Lahn. N-a-Benzoyl-DL-arginine-4-nitro- 
anilide. HC1 (BANI), Fluka AG, Buchs, Switzerland. 
2.2. Inactivation o f  trypsin, plasmin, and thrombin 
Trypsin (40 ~g/ml), plasmin (14 caseinolytic units/ 
ml), or thrombin (50 NIH-units/ml) were incubated 
at 25 ° with suitable concentrations of BGB or NBGB. 
All reactants were dissolved in 0.1 M tris-HC1 buffer 
containing 0.05 M NaC1 and 0.01 M CaC12, pH 7.2. 
At different imes, samples of the incubation mixture 
were taken and the reaction between enzyme and 
inhibitor was stopped by addition of substrate (BANI). 
The residual activity of the enzymes was measured 
by determining the hydrolysis of BANI (0.002 M) at 
pH 7.2 and 25 ° as described previously [7]. 
3. Results 
3.1. Inhibition o f  trypsin 
By incubation of trypsin with one of the guani- 
dinobenzoic acid esters, an inhibition of the enzyme 
is evident. The extent of the inhibition is dependent 
on the concentration f the ester and the incubation 
time. The reaction shows second order kinetics as can 
be seen from a plot of log a x (~_--~) against he reaction 
time (fig. 1). Second order rate constants were deter- 
mined graphically from the slope of the resulting 
lines as a parameter of the inhibitory activity (table 1). 
According to the kinetics described for trypsin in- 
activation by both the esters, formation of a covalent 
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Table 1 
Rate constants for the reaction of benzyl 4-guanidinobenzoate 
t . . . 
(BGB) and 4 -mtrobenzyl 4-guamdmobenzoate (NBGB) with 
trypsin, plasmin, and thrombin at pH 7.2• 
lnhibitors 
k* (M -1 . sec -1) 
Trypsin Plasmin Thrombin 
Benzyl 4-guanidinobenzoate 930 20 
p . . . 
4 -Nltrobenzyl 4-guamdlno- 2500 70 
benzoate 
0.9 
1.1 
* Second order ate constant. 
zp 
4,6, 
t~ l  . .Q  
0,4. 
T im (Minutes) 
Fig. 1. Inactivation of trypsin (8.4 X 10 -7 M) by 4'-guanidi- 
nobenzoate (o= 2.1 X 10 -7 M, • = 4.2 X 10 -7 M, * = 6.3 X 
10 -7 M). (b = starting concentration f the inhibitor, a = 
starting concentration f the enzyme, x = quantity of enzyme 
inactivated attime t). 
bond is supposed. Evidently, the inhibitors react like a 
substrate with trypsin and hydrolysis tops at the step 
of acylenzyme. The reaction of the inhibitors results 
in the formation of 4-guanidinobenzoic acid ester of 
trypsin (transesterification). Therefore, only one split 
product (benzylalcohol r 4-nitrobenzylalcohol) can 
appear and the number of ester bonds must remain 
constant during the inactivation. 
For demonstrating the occurrence of this split pro- 
duct, equimolar amounts (10 -3  M) of trypsin and 
4'-nitrobenzyl 4-guanidinobenzoate were incubated at 
pH 7.2 and 25 ° for 10 rain. After the incubation, 
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Fig. 2. Transesterification during the inactivation of trypsin 
• r . . . 
by equmaolar amounts of 4 -mtrobenzyl 4-guamdmobenzoate. 
Ester concentration in the trypsin-free supernatant (o) and in 
the trypsin precipitate suspended in equal volumes of water (e). 
Trypsin activity (- - -). 
benzyl alcohol and 4-nitrobenzyl alcohol were de- 
tected by means of thin layer chromatography. In 
order to demonstrate he transesterification, equal 
volumes of 4 X 10 -4 M solutions of trypsin and 
4'-nitrobenzyl 4-guanidinobenzoate were incubated 
at pH 7.2 at 25 °. Samples were taken at different 
times and mixed with equal volumes of 6 percent 
perchloric acid. The precipitate was centrifuged. The 
concentration of ester in the supernatant and in the 
precipitate was determined by the hydroxamic acid 
method [8]. The time-dependent decrease of the ester 
concentration i the trypsin-free supernatant corres- 
ponds with an increase of the ester content in the 
trypsin precipitate (fig. 2). 
3.3. Inhibition of plasmin and thrombin 
NBGB and BGB inhibit not only trypsin but also 
plasmin and thrombin. The inhibition of plasmin and 
thrombin takes place in the same manner, as in the 
case of trypsin. In order to evaluate the velocity of 
the inactivation, the second order rate constants of 
the inhibition of  plasmin and thrombin were deter- 
mined at pH 7.2 in a similar manner, as described 
above (table 1). First order kinetics were applied be- 
cause an important excess of inhibitor was required 
for the inactivation of plasmin and thrombin during 
the investigated time interval. Consequently, plasmin 
and thrombin are inactivated much more slowly than 
trypsin. 
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4. Discussion 
The result that BGB and NBGB are stronger in- 
hibitors of trypsin than benzyl 4-amidinobenzoate 
was surprising. In other investigations [ 1, 7, 9, 10] 
benzamidin compounds were accordingly found to 
be more potent competitive inhibitors of trypsin than 
the corresponding derivatives of phenylguanidine. Our 
investigations on the mechanism of the trypsin inac- 
tivation by benzyl 4-guanidinobenzoate nd 4'-nitro- 
benzyl 4-guanidinobenzoate elucidate the especially 
strong inhibition of trypsin by these compounds. 
The strong inhibition is not caused by a competitive 
mechanism but by acylation of  the enzyme by these 
esters. The deacylation takes place so slowly that a 
practically irreversible inhibition results. The in- 
activation runs relatively rapidly in comparison 
with other irreversible inhibitors of trypsin (TLCK 
[ 11 ], DFP [ 12], diphenyl carbamyl chloride 
[13], 4-guanidinobenzoic a id ethyl ester [4]). 
Plasmin and thrombin are inhibited in the same 
way. However, the plasmin inactivation is 30-50  
times slower. The inactivation of thrombin was found 
to be about 1000 times lower. Similar relations of the 
rates for the inactivation of trypsin, plasmin, and 
thrombin were found by Chase and Shaw [3]. 
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